plastic surgery, bad plastic surgery picture, plastic surgery, bad plastic surgery picture, plastic surgery, bad plastic surgery picture, plastic surgery, plastic surgery prices, bad plastic surgery picture, plastic surgery washington dc, plastic surgery, plastic surgery hawaii

plastic surgery | bad plastic surgery picture Information

plastic surgery Resources

bad plastic surgery picture News

Sunday, November 20, 2005

TORRANCE, Calif. -- Eye Dynamics, Inc. (OTCBB:EYDY), a leading provider of health and safety products, today announced the signing by both parties of a definitive Merger Agreement with Superior, Colorado-based OrthoNetx, Inc., a leading provider of medical devices for osteo. Pursuant to the plan of merger approved by Boards of Directors of both companies, the merger will occur as a stock exchange transaction whereby OrthoNetx shares will be exchanged for Eye Dynamics shares. Thereafter, it is intended that Eye Dynamics, the surviving entity, will be renamed AcuNetx, Inc. Completion of the merger is subject to customary conditions, including regulatory approvals.

Terry R. Knapp, President and CEO of OrthoNetx, will assume the position of CEO and a Director of the new, merged company. Stephen D. Moses, Vice Chairman of MP Biomedicals, Inc., Vice Chairman of Galen Capital Group, LLC and currently a member of the OrthoNetx Board of Directors will serve as Chairman of the Board of the combined companies. Other Directors will include Ron Waldorf, co-founder and current CEO of Eye Dynamics; Charles Phillips, co-founder and former CEO of Eye Dynamics; Randolph Robinson, MD, DDS, founder and current Chairman of OrthoNetx; Robert Corrigan, a current Director of OrthoNetx; and William P. Danielczyk, a current Director of OrthoNetx and Chairman of Galen Capital Group, LLC.

The new company expects to emerge as a premier provider of medical devices in the healthcare field with innovative product lines, synergies that expand offerings and the ability to enhance medical sales opportunities and fuel continued expansion.

"The merger of OrthoNetx and Eye Dynamics brings significant opportunities for growth and innovation," said both Knapp and Waldorf. "The strength of the management team, breadth of product offering and vision for the future, solidly positions the combined company to bring exciting developments to market."

About Eye Dynamics, Inc.

Eye Dynamics is in the business of producing and marketing patented proprietary products and other services for the institutional, medical and government markets. The company is a leader in the Video ENG medical product market, having invented the Video ENG system and brought it to market in 1994. SafetyScope, the company's latest product, is designed for the "fitness-for-duty" screening of workers. SafetyScope is simple to use, takes only 90 seconds and does not require any bodily fluids like urine-based drug testing. It automates the manual methods of evaluating eye responses of an individual to detect neurological signs of impairment used by law enforcement throughout the United States. To find out more about Eye Dynamics, Inc. visit:

About OrthoNetx, Inc.

OrthoNetx, Inc. designs, develops, manufactures and markets patented, FDA-approved medical devices and systems for osteoplastic surgery and distraction osteogenesis -- the practice of generating, forming and molding bone. Physician customers include plastic surgeons, oral and maxillofacial surgeons, otolaryngologists, and orthopedic surgeons who correct deformities and deficiencies of the skeleton caused by errors of birth, trauma, infections and tumors. Osteo is applicable to all areas of the skeleton, including the skull and face, jaws, long bones of the upper and lower extremities, hands, wrists, feet, ankles, and the spine. The privately-held company is headquartered in Superior, CO. For more information visit:

Safe Harbor for Forward Looking Statements

This news release includes forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

COPYRIGHT 2005 Business Wire

Colorado Springs, Colo. -- Patients seeking to minimize risks and complications associated with midface lifts might do well to consider the transblepharoplasty midface lift, according to Michael Patipa, M.D.

"Via a lower-lid blepharoplasty incision," Dr. Patipa says, "I go down to the descended midface and elevate the descended malar fat pad. I use three points of fixation. One is tightening of the lateral canthal tendon (see related story p. 66). The second is a suture that simulates the orbitomalar ligament, which is a suture that's placed at the junction of the inferior lateral orbital rim, and when I pull the midface up, that suture holds the midface in an elevated position. Third, I place three sutures that pull the orbicularis up to the lateral orbital rim periosteum. And with those three sutures, I'm able to elevate the descended malar fat pad and reposition the eyelid and midface back to where they used to be prior to their descent."

Dr. Patipa is an ocular plastic surgeon and practices at Oculoplastic and Orbital Consultants, West Palm Beach, Fla.

Elevating the malar fat pad includes dissecting skin 6 to 8 mm down and making an incision in the orbicularis oculi muscle lateral to the lateral canthal angle down to the lateral orbital rim. Then, Dr. Patipa makes a preperiosteal dissection inferiorly to below and around the zygomaticofacial nerve and vascular complex. From this point, one can elevate the malar fat pad and back-cut tissues to mobilize it (Plast Reconstr Surg. 113: 1459, 2004.).

Lateral canthal tendon

When it comes to tightening the lateral canthal tendon, he believes methods to suspend the lateral retinaculum work well for patients with minimal or no laxity of the lateral canthal tendon.

However, for the vast majority of patients who surfer from midface descent and lateral canthal tendon laxity, he advises returning this tendon to its normal anatomic insertion. Once the lateral canthal tendon (and, with a 5-0 Vicryl suture, the lower eyelid) has been tightened, it's possible to elevate the midface by pulling up on it via the lateral orbicularis oculi muscle.

The foregoing approach cuts complications by design.

Dr. Patipa explains, it's a direct access via a lower-lid blepharoplasty operation, so it's just a couple of additional steps above and beyond the cosmetic lower-lid operation that let the midface be elevated in conjunction with the blepharoplasty. I emphasize that there are many different procedures available for elevating a midface. And you have to customize the procedure based on your surgical armamentarium and what the patient needs."

Procedures ranging from conventional facelifts to endoscopic browlifts all lend themselves to different approaches to midface lifts.

"Based on what the patient needs," he says, "you implement the procedure that best applies to giving them the best cosmetic result." About the only situations in which Dr. Patipa won't perform the surgery are when its not needed or when patients desire facelifts as well, which he does not perform.

Drawbacks, advantages

As for the procedure's drawbacks, he says, "There are always potential risks. You just have to weigh the risk-reward ratio and decide what's right for the patient."

The greatest advantage of the transblepharoplasty midface lift is its direct, straightforward nature. As such, it helps minimize risks including swelling, chemosis and undercorrection that can plague midface procedures.

In a series of 65 transblepharoplasty midface rejuvenation elevations recently reported by Dr. Patipa (Plast Reconstr Surg. 113: 1459, 2004.), 50 were performed on patients who had undergone previous eyelid and/or facial cosmetic surgery. Twenty-four patients in the series reported dissatisfaction with results of their previous cosmetic surgeries. Their complaints included sad-looking and round eyes, as well as dry eyes and ocular irritation. As part of their surgery, all patients received lateral canthal tendon tightening. Only two patients reported residual laxity of this tendon, which Dr. Patipa attributes most likely to postoperative edema suture stretching. It should be noted, however, that both of these patients experienced many previous cosmetic surgeries and secondary reoperations prior to reaching him.

Of the 65 patients, only two experienced residual lower eyelid retraction after midface elevation. Neither had a spacer graft, though Dr. Patipa says they probably should have. Six patients reported thickening of their lateral canthal scars, which he corrected successfully through excision. Of these six, most were early patients who had temporal brow ptosis, which might have been alleviated through temporal browlifts. Dr. Patipa began recommending this procedure more strongly in his later cases.

Disclosure: Dr. Patipa reports no finacial Interests related to this article.

For more information:

COPYRIGHT 2005 Advanstar Communications, Inc.